Joseph Vetro

Associate Professor

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joseph Vetro is an Associate Professor at the University of Nebraska Medical Center in the United States. His research focuses on immunostimulation, particularly related to methicillin-resistant Staphylococcus aureus and breast cancer therapies. Recent articles highlight advancements in host-derived immunostimulants and RNAi-based treatments. His work aims to enhance both mucosal and systemic immune responses through innovative therapeutic strategies.

Articles (5)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (2)

Samuel Cohen

Professor

University of Nebraska Medical Center

UNITED STATES

View details

Derek Smith

Faculty/Professor

Creighton University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joseph Vetro

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> USA300

Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization

Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC

Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer

Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

Collaborators (2)

Samuel Cohen

Derek Smith

Make your next move.